ORLANDO, Fla. — Rusfertide, a weekly self-injected peptide, maintained control of hematocrit levels and reductions in ...

The Three Laws of Robotics won't apply to a little needlework. A collaboration among Northwestern Medicine, other clinical sites and a company developing an automated phlebotomy machine will test ...

Patients with polycythemia vera (PV) taking the investigational therapy rusfertide were able to largely maintain hematocrit control and avoid the need for phlebotomy over 52 weeks, according to ...

Blood loss from phlebotomy is associated with hospital-acquired anemia, according to an article published in Archives of Internal Medicine. The researchers studied 17,676 patients with acute ...